OpenAlex
PricingAboutJobs
Log inGet started
Work

Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype

HTML

Year: 2020
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.0c00566
Authors: Christopher R. Wellaway, Paul Bamborough, Sharon G. Bernard, Chun-wa Chung, Peter D. Craggs, Leanne Cutler, Emmanuel H. Demont, John P. Evans, Laurie Gordon, Bhumika Karamshi, Antonia J. Lewis, Matthew J. Lindon, Darren J. Mitchell, Inmaculada Rioja, Peter E. Soden, Simon Taylor, Robert J. Watson, Rob Willis, James M. Woolven, Beata S. Wyspiańska, William J. Kerr, Rab K. Prinjha
Institutions: GlaxoSmithKline Research & Development Limited (United Kingdom), University of Strathclyde
Language: English

Topic: Protein Degradation and Inhibitors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: BET inhibitors, I-BET151, structure-based drug design, anti-inflammatory activity, antiproliferative activity, epigenetic regulators, BRD4, BRD2, BRD3, BRDT

Open Access status: closed
OpenAlex ID: W3047589966
FWCI: 2.412
Cites: 47
Cited by: 59
Related to: 10
Parts: 2
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security